0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases

Buy Now

Human Retroviral Infections - Immunological and Therapeutic Control (Hardcover, 2002 ed.) Loot Price: R4,344
Discovery Miles 43 440
You Save: R849 (16%)
Human Retroviral Infections - Immunological and Therapeutic Control (Hardcover, 2002 ed.): Kenneth E. Ugen, Mauro Bendinelli,...

Human Retroviral Infections - Immunological and Therapeutic Control (Hardcover, 2002 ed.)

Kenneth E. Ugen, Mauro Bendinelli, Herman Friedman

Series: Infectious Agents and Pathogenesis

 (sign in to rate)
List price R5,193 Loot Price R4,344 Discovery Miles 43 440 | Repayment Terms: R407 pm x 12* You Save R849 (16%)

Bookmark and Share

Expected to ship within 12 - 17 working days

The discovery of the human T cell leukemia virus type I in the late 1970s heralded a new era in retrovirology. For the first time, it was demonstrated that a retrovirus could play a role in the development of a human disease, in this case adult T cell leukemia (ATL). Several years later, the acquired immunodeficiency syndrome (AIDS) epidemic began, and it was dem- strated that a retrovirus, originally designated the human T cell lymp- tropic virus type 3, was the causal agent of this syndrome. This virus, later named the human immunodeficiency virus type 1 (HIV-1), has since been extensively studied in terms of its pathogenesis as well as its ability to elicit immune responses. In that time, a tremendous amount of information has been obtained about the virus. Although recent drug regimens have been useful in significantly lowering viral loads and perhaps maintaining an asymptomatic state among individuals infected with HIV-1, an established "cure" for AIDS eludes us. In addition, the effective drug therapies are very expensive, and are not available to infected people in the third world, where greater than 90% of new infections occur. Furthermore, the development of viral resistance against the drug therapies is an additional concern. Despite extensive study, no effective vaccine has been developed. One of the problems in developing an effective vaccine against HIV-1 is the ability of the virus, particularly in the immunogenic envelop glycoprotein, to undergo amino acid hypervariability.

General

Imprint: Kluwer Academic / Plenum Publishers
Country of origin: United States
Series: Infectious Agents and Pathogenesis
Release date: June 2000
First published: 2002
Editors: Kenneth E. Ugen • Mauro Bendinelli • Herman Friedman
Dimensions: 235 x 155 x 22mm (L x W x T)
Format: Hardcover
Pages: 368
Edition: 2002 ed.
ISBN-13: 978-0-306-46222-1
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases > General
LSN: 0-306-46222-2
Barcode: 9780306462221

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners